Trials / Conditions / Nonsmall Cell Lung Cancer Stage III
Nonsmall Cell Lung Cancer Stage III
6 registered clinical trials studyying Nonsmall Cell Lung Cancer Stage III — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance NCT05692635 | Wake Forest University Health Sciences | Phase 2 |
| Recruiting | Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer NCT05696782 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC NCT05873439 | H. Lee Moffitt Cancer Center and Research Institute | EARLY_Phase 1 |
| Terminated | Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients NCT04398199 | Wake Forest University Health Sciences | Phase 2 |
| Terminated | Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis NCT04040244 | Wake Forest University Health Sciences | N/A |
| Terminated | Cisplatin and Pemetrexed With Radiation Followed by Lobectomy NCT01373463 | Medical University of South Carolina | Phase 1 |